NCT00493714

Brief Summary

Primary Objectives:

  1. 1.To determine the proportion of patients who experience partial or complete recollection of symptoms of delirium and the level of distress associated with this recall.
  2. 2.To determine caregiver's level of distress associated with the patient's episode of delirium.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
200

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jul 2005

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2005

Completed
2 years until next milestone

First Submitted

Initial submission to the registry

June 27, 2007

Completed
1 day until next milestone

First Posted

Study publicly available on registry

June 28, 2007

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2007

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2007

Completed
Last Updated

July 30, 2012

Status Verified

July 1, 2012

Enrollment Period

2.4 years

First QC Date

June 27, 2007

Last Update Submit

July 27, 2012

Conditions

Keywords

Advanced CancerDeliriumRestlessnessConfusionCaregiversQuestionnaire

Outcome Measures

Primary Outcomes (2)

  • Patient Level of Distress as related to Level of Delirium

    Level of distress patients experience associated with delirium recall, made on a 0-4 numerical rating scale with 0=not at all and 4=extremely distressed. Summarized as a median score and as the most frequent response.

    2 Years

  • Number of patients who have partial or complete memory of experiencing any signs of delirium (confusion or restlessness)

    Interview with full assessment including demographic information, MMSE (Mini-Mental State Exam), DEQ (The Delirium Experience Questionnaire), and Delirium Recall Questionnaire for patient who experience complete recovery from an episode of delirium

    2 Years

Study Arms (2)

Arm 1 (Patient)

Cancer patient who recently experienced confusion or restlessness.

Behavioral: Questionnaire

Arm 2 (Caregiver)

Caregivers of cancer patients who recently experienced confusion or restlessness.

Behavioral: Questionnaire

Interventions

QuestionnaireBEHAVIORAL

Surveys lasting 30 minutes or more.

Arm 1 (Patient)Arm 2 (Caregiver)

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Advanced cancer patient having had an episode of delirium with complete recover; and their caregivers, age 18 years or older.

You may qualify if:

  • Presence of advanced cancer, defined as local recurrent and/or metastatic.
  • History of an episode of delirium during the patient's current inpatient admission, diagnosis of delirium will be made by one of the palliative care specialists according to DSM-IV-TR criteria.
  • Ability to communicate in the English language.
  • Written informed consent signed by the patients and the participating caregivers.
  • MDAS \[Memorial Delirium Assessment Scale\] \< 13 (Scores of 13 or above likely reflect the presence of delirium).
  • Patients will be recruited from the palliative care mobile team or the inpatient palliative care unit.

You may not qualify if:

  • Refusal of both the patient and their caregiver to complete assessments
  • Inability to complete assessment due to sensorial deficits other than cognition; e.g. blindness, deafness, aphasia, etc., that might impact the patient's ability to recall the episode of delirium.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

UT MD Anderson Cancer Center

Houston, Texas, 77030, United States

Location

Related Links

MeSH Terms

Conditions

DeliriumPsychomotor AgitationConfusion

Interventions

Surveys and Questionnaires

Condition Hierarchy (Ancestors)

Neurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and SymptomsNeurocognitive DisordersMental DisordersDyskinesiasPsychomotor DisordersAberrant Motor Behavior in DementiaBehavioral SymptomsBehavior

Intervention Hierarchy (Ancestors)

Data CollectionEpidemiologic MethodsInvestigative TechniquesHealth Care Evaluation MechanismsQuality of Health CareHealth Care Quality, Access, and EvaluationPublic HealthEnvironment and Public Health

Study Officials

  • Eduardo Bruera, MD

    M.D. Anderson Cancer Center

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 27, 2007

First Posted

June 28, 2007

Study Start

July 1, 2005

Primary Completion

December 1, 2007

Study Completion

December 1, 2007

Last Updated

July 30, 2012

Record last verified: 2012-07

Locations